• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

证明静脉闭塞无法释放血管性血友病因子多聚体。

Demonstration that venous occlusion fails to release von Willebrand factor multimers.

作者信息

Casonato A, Pontara E, Bertomoro A, Dannhauser D, Sartori M T, Patrassi G, Boeri G, Girolami A

机构信息

University of Padua Medical School, Institute of Medical Semeiotics, Italy.

出版信息

Blood Coagul Fibrinolysis. 1995 Sep;6(6):574-8. doi: 10.1097/00001721-199509000-00012.

DOI:10.1097/00001721-199509000-00012
PMID:7578901
Abstract

The acute simultaneous release of tissue plasminogen activator (t-PA) and von Willebrand factor (vWF) from endothelial cells in response to a variety of agonists including thrombin, DDAVP, histamine and adrenalin has been described. In the present study we investigated the effect of venous occlusion on the circulating levels of t-PA and vWF, as well as the molecular organization of vWF in 20 normal subjects. After occlusion a significant increase in plasma t-PA levels was observed even after the values were corrected for haemoconcentration. Venous occlusion also enhanced plasma vWF values, but the increase was abolished when the correction for haemoconcentration was introduced. Following venous occlusion, no circulating abnormally large vWF multimers were detected in the subjects studied. These forms are normally not present in the circulation and are released from endothelial cells through the regulated vWF pathway; their absence therefore seems to demonstrate that this pathway is not activated after venous occlusion. Since occlusion does not enhance vWF synthesis, the increase in vWF observed in the subjects investigated may be fully attributed to haemoconcentration.

摘要

已有研究描述了内皮细胞在凝血酶、去氨加压素、组胺和肾上腺素等多种激动剂作用下,组织纤溶酶原激活物(t-PA)和血管性血友病因子(vWF)的急性同时释放。在本研究中,我们调查了静脉阻塞对20名正常受试者循环中t-PA和vWF水平以及vWF分子结构的影响。阻塞后,即使对血液浓缩进行校正,血浆t-PA水平仍显著升高。静脉阻塞也会提高血浆vWF值,但引入血液浓缩校正后,这种升高就消失了。静脉阻塞后,在所研究的受试者中未检测到循环中异常大的vWF多聚体。这些形式通常不存在于循环中,而是通过受调控的vWF途径从内皮细胞释放;因此,它们的不存在似乎表明该途径在静脉阻塞后未被激活。由于阻塞不会增强vWF合成,在研究的受试者中观察到的vWF增加可能完全归因于血液浓缩。

相似文献

1
Demonstration that venous occlusion fails to release von Willebrand factor multimers.证明静脉闭塞无法释放血管性血友病因子多聚体。
Blood Coagul Fibrinolysis. 1995 Sep;6(6):574-8. doi: 10.1097/00001721-199509000-00012.
2
Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.在血管性血友病患者中,若血小板血管性血友病因子含量较低,输注去氨加压素后组织型纤溶酶原激活物(t-PA)释放受损。
Blood Coagul Fibrinolysis. 1992 Apr;3(2):149-53. doi: 10.1097/00001721-199204000-00003.
3
Study of endothelial t-PA and vWf in normal subjects and in von Willebrand's disease.正常受试者和血管性血友病患者内皮组织型纤溶酶原激活物及血管性血友病因子的研究。
Blood Coagul Fibrinolysis. 1994 Jun;5(3):329-34.
4
Plasma levels of von Willebrand factor and plasminogen activator in patients with arterial thromboembolism--with special reference to their correlation to the increased catabolism of both fibrinogen and platelets.
Nihon Ketsueki Gakkai Zasshi. 1989 Sep;52(6):1105-14.
5
Impaired release of tissue plasminogen activator from the endothelium in Graves' disease - indicator of endothelial dysfunction and reduced fibrinolytic capacity.格雷夫斯病中内皮组织纤溶酶原激活物释放受损——内皮功能障碍和纤溶能力降低的指标。
Eur J Clin Invest. 1998 Dec;28(12):1050-4. doi: 10.1046/j.1365-2362.1998.00381.x.
6
Granulocyte proteases do not process endothelial cell-derived unusually large von Willebrand factor multimers to plasma vWF in vivo.粒细胞蛋白酶在体内不会将内皮细胞衍生的异常大的血管性血友病因子多聚体加工成血浆血管性血友病因子。
Am J Hematol. 1991 Jun;37(2):80-3. doi: 10.1002/ajh.2830370204.
7
Secretory response of the vessel wall to DDAVP and venous occlusion in von Willebrand's disease.血管性血友病中血管壁对去氨加压素和静脉阻塞的分泌反应。
Acta Haematol Pol. 1994;25(3):261-8.
8
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.1型和2型先天性血管性血友病患者血管性血友病因子参数对去氨加压素的反应:诊断和治疗意义
Semin Thromb Hemost. 2002 Apr;28(2):111-32. doi: 10.1055/s-2002-27814.
9
Venous occlusion does not release von Willebrand factor, factor VIII or PAI-1 from endothelial cells--the importance of consensus on the use of correction factors for haemoconcentration.静脉阻塞不会从内皮细胞释放血管性血友病因子、凝血因子VIII或纤溶酶原激活物抑制剂-1——关于血液浓缩校正因子使用共识的重要性。
Thromb Haemost. 1993 Jan 11;69(1):91, 93.
10
The high molecular weight form of endothelial cell von Willebrand factor is released by the regulated pathway.内皮细胞血管性血友病因子的高分子量形式通过调节途径释放。
Br J Haematol. 1991 Oct;79(2):239-45. doi: 10.1111/j.1365-2141.1991.tb04528.x.